Showing results (741-750 of 821) with videos related to

Sort By:
Pageof 83
Cancers|May 14, 2022
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic TreatmentAndrea Emanuele Guerini, Alessandra Tucci, Filippo Alongi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2022
Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II TrialAlexander Drilon, Vivek Subbiah, Oliver Gautschi, et al.
Frontiers in Oncology|July 20, 2023
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experiencePaolo Borghetti, Giulia Volpi, Giorgio Facheris, et al.
Oral Oncology|February 14, 2022
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinomaDavide Lombardi, Michele Tomasoni, Luigi Lorini, et al.
Journal of Inorganic Biochemistry|October 2, 2022
Synthesis, characterization, antioxidant potential, and cytotoxicity screening of new Cu(II) complexes with 4-(arylchalcogenyl)-1H-pyrazoles ligandsAdriana C Pinheiro, Franciele F Busatto, Bruna T Schaefer, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2024
Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study)Lyria Amari, Pascale Tomasini, Emmanuelle Dantony, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistanceLuca Triggiani, Rosario Mazzola, Davide Tomasini, et al.
Cells|September 23, 2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway InhibitorsSilvia Codenotti, Daniela Zizioli, Luca Mignani, et al.
Annals of Neurology|March 23, 2001
Genome scan of idiopathic generalized epilepsy: evidence for major susceptibility gene and modifying genes influencing the seizure typeM Durner, M A Keddache, L Tomasini, et al.
Journal of Extracellular Biology|December 4, 2023
Integrating extracellular vesicle and circulating cell-free DNA analysis using a single plasma aliquot improves the detection of HER2 positivity in breast cancer patientsVera Mugoni, Yari Ciani, Orsetta Quaini, et al.
Pageof 83